Tuesday, July 15, 2014
A new study by a Florida State University researcher reveals that a new dietary supplement is superior to calcium and vitamin D supplements when it comes to bone health.
Post-menopausal women are well aware of the risks of delicate bones and fractures. However, a national survey of women taken for AIDP, Inc., the supplier of KoACT, a patented combination of collagen and calcium, found that almost half (49%) are not taking any bone health supplement to address this major health issue. And, even fewer are not aware of the newest science supporting that a calcium-collagen combination is optimal for bone health.
“Conventional thinking often entails the use of calcium and Vitamin D supplements; however, these random controlled clinical studies on KoACT demonstrate that calcium alone is not the best option,” said Dr Jennifer Gu, AIDP’s VP of research and development.
“It is medically important for post-menopausal women to know that achieving optimal bone health requires using a product, like KoACT, that 'mimics Mother Nature,' in stopping bone loss by helping to build bone strength and slows bone resorption, the destruction, disappearance, or dissolution of bones. Calcium alone is not the right answer.”
KoACT is a patented chelated compound of calcium and hydrolyzed collagen peptides, said the company, and data from animal and one human study support its potential to increase both bone strength and bone mineral density.
Bahram H. Arjmandi, director of the Center for Advancing Exercise and Nutrition Research on Aging (CAENRA) at Florida State, studied for one year the impact of the dietary supplement KoACT versus calcium and vitamin D on bone loss.
Calcium and vitamin D are generally thought of as the first line of defense when it comes to bone health, but Arjmandi’s research found that the calcium-collagen chelate was more effective in slowing bone loss.
“This is crucial information for the health of women,” Arjmandi said. “Women in early menopause experience rapid bone loss.”
A group of 39 women were randomly divided into two groups, with the control group taking a capsule that was a mix of calcium and vitamin D. The other group took the calcium-collagen chelate.
The women taking the calcium-collagen chelate saw substantially less bone loss than the control group over a year’s time. The group taking the calcium-collagen chelate, saw a loss of 1.23 percent in bone mineral density, while the control group saw a 3.75 percent loss.
Arjmandi acknowledged he was “pleasantly surprised” by the outcomes and hopes that the supplement will be used in the future as a way to prevent bone density loss.
“We take our bones for granted,” Arjmandi said. “If we do not prevent the loss of bone, our bones will be looking for an excuse to break.”
In the United States, more than 44 million people have or are at risk for osteoporosis, a chronic and potentially debilitating condition. Although there are some drugs available to treat it, most medical professionals have turned to nutrition and exercise to treat the condition.